614398735	614398735	CD	B-NP	O
|	|	NN	I-NP	O
OMC	OMC	NN	I-NP	O
|	|	NN	I-NP	O
61314445	61314445	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
3125941	3125941	CD	B-NP	O
|	|	CC	I-NP	O
5/29/2006	5/29/2006	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
chf	chf	NN	I-NP	O
exacerbation	exacerbation	NN	I-NP	O
|	|	NN	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
5/7/2006	5/7/2006	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
11/19/2006	11/19/2006	CD	B-NP	O
******	******	SYM	I-NP	O
FINAL	FINAL	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NN	I-NP	O
******	******	SYM	B-VP	O
EVANKO	EVANKO	NN	B-NP	O
,	,	,	O	O
BENEDICT	BENEDICT	NN	B-NP	O
734-70-74-4	734-70-74-4	CD	I-NP	O
Dalemilci	Dalemilci	NNP	I-NP	O
Lake	Lake	NNP	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
MED	MED	NNP	B-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
PATIENT	PATIENT	NNP	I-NP	O
ON	ON	NNP	I-NP	O
:	:	:	O	O
1/29/06	1/29/06	CD	B-NP	O
AT	AT	NN	I-NP	O
11	11	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	NNP	I-NP	O
CONTINGENT	CONTINGENT	NNP	I-NP	O
UPON	UPON	NNP	I-NP	O
Not	Not	NNP	I-NP	O
Applicable	Applicable	NNP	I-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
RHATIGAN	RHATIGAN	NNP	B-NP	O
,	,	,	O	O
WENDELL	WENDELL	NNP	B-NP	O
E.	E.	NNP	I-NP	O
E.	E.	NNP	I-NP	O
M.	M.	NNP	I-NP	O
CODE	CODE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Home	Home	NN	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
services	service	NNS	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
ACETYLSALICYLIC	ACETYLSALICYLIC	NN	B-NP	O
ACID	ACID	NN	I-NP	O
81	81	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
ATORVASTATIN	ATORVASTATIN	NNP	I-NP	O
80	80	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
COREG	COREG	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
CARVEDILOL	CARVEDILOL	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
3.125	3.125	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
HOLD	HOLD	NN	I-NP	O
IF	IF	NN	I-NP	O
:	:	:	O	O
SBP	SBP	NN	B-NP	B-protein
<	<	JJR	B-NP	O
90	90	CD	I-NP	O
or	or	CC	O	O
P	P	NN	B-NP	O
<	<	SYM	O	O
55	55	CD	B-NP	O
Instructions	Instruction	NNS	I-NP	O
:	:	:	O	O
if	if	IN	B-SBAR	O
held	hold	VBN	B-VP	O
,	,	,	O	O
please	please	VB	B-VP	O
call	call	NN	B-NP	O
HO	HO	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Take	Take	NNP	I-NP	O
consistently	consistently	RB	B-ADVP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
or	or	CC	B-PP	O
on	on	IN	B-PP	O
empty	empty	JJ	B-NP	O
stomach	stomach	NN	I-NP	O
.	.	.	O	O

Number	Number	NN	B-NP	O
of	of	IN	B-PP	O
Doses	Dose	NNS	B-NP	O
Required	Require	VBN	B-VP	O
-LRB-	-LRB-	HYPH	B-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
6	6	CD	B-NP	O
PLAVIX	PLAVIX	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
CLOPIDOGREL	CLOPIDOGREL	NN	I-NP	O
-RRB-	-RRB-	HYPH	O	O
75	75	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
LASIX	LASIX	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
FUROSEMIDE	FUROSEMIDE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
80	80	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
IN	IN	NNP	I-NP	O
AM	AM	NNP	I-NP	O
May	May	NNP	I-NP	O
INSULIN	INSULIN	NNP	I-NP	O
70/30	70/30	CD	I-NP	O
HUMAN	HUMAN	NN	I-NP	B-DNA
50	50	CD	B-NP	I-DNA
UNITS	UNITS	NNP	I-NP	I-DNA
QAM	QAM	NNP	I-NP	I-DNA
;	;	:	O	I-DNA
35	35	CD	B-NP	I-DNA
UNITS	UNITS	NNP	I-NP	I-DNA
QPM	QPM	NNP	I-NP	I-DNA
SC	SC	NNP	I-NP	I-DNA
50	50	CD	I-NP	I-DNA
UNITS	UNITS	NNP	I-NP	I-DNA
QAM	QAM	NNP	I-NP	I-DNA
35	35	CD	I-NP	I-DNA
UNITS	UNITS	NNP	I-NP	I-DNA
QPM	QPM	NNP	I-NP	O
IMDUR	IMDUR	NNP	I-NP	O
ER	ER	NN	I-NP	B-protein
-LRB-	-LRB-	NNP	I-NP	O
ISOSORBIDE	ISOSORBIDE	NNP	I-NP	O
MONONITRATE	MONONITRATE	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
SR	SR	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
30	30	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
IN	IN	NNP	I-NP	O
AM	AM	NNP	I-NP	O
January	January	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Give	Give	NNP	I-NP	O
on	on	IN	B-PP	O
an	an	DT	B-NP	O
empty	empty	JJ	I-NP	O
stomach	stomach	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
give	give	VBP	B-VP	O
1hr	1hr	NN	B-NP	O
before	before	IN	B-SBAR	O
or	or	CC	O	O
2hr	2hr	NN	B-NP	O
after	after	IN	B-PP	O
food	food	NN	B-NP	B-protein
-RRB-	-RRB-	NN	I-NP	I-protein
LISINOPRIL	LISINOPRIL	NN	I-NP	I-protein
10	10	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
DAILY	DAILY	NN	I-NP	I-protein
HOLD	HOLD	NN	I-NP	I-protein
IF	IF	NN	I-NP	I-protein
:	:	:	O	O
SBP	SBP	NN	B-NP	B-protein
<	<	JJR	B-NP	O
90	90	CD	I-NP	O
and	and	CC	O	O
call	call	VB	B-VP	O
HO	HO	NNP	B-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
3/9/06	3/9/06	CD	B-NP	O
by	by	IN	B-PP	O
REICKS	REICKS	NNP	B-NP	O
,	,	,	O	O
JACQUES	JACQUES	NNP	B-NP	O
M	M	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
M.P.H.	M.P.H.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
SPIRONOLACTONE	SPIRONOLACTONE	NNP	B-NP	O
&	&	CC	I-NP	O
LISINOPRIL	LISINOPRIL	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
POTASSIUM	POTASSIUM	NNP	B-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
&	&	CC	I-NP	O
LISINOPRIL	LISINOPRIL	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
POTASSIUM	POTASSIUM	NNP	B-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
&	&	CC	I-NP	O
LISINOPRIL	LISINOPRIL	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
monitor	monitor	NN	B-NP	O
METAMUCIL	METAMUCIL	NNP	I-NP	O
SUGAR	SUGAR	NNP	I-NP	O
FREE	FREE	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
PSYLLIUM	PSYLLIUM	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
METAMUCIL	METAMUCIL	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
SU	SU	NNP	I-NP	O
...	...	:	O	B-protein
-RRB-	-RRB-	SYM	B-NP	I-protein
1	1	CD	I-NP	I-protein
PACKET	PACKET	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
DAILY	DAILY	NN	I-NP	I-protein
SPIRONOLACTONE	SPIRONOLACTONE	NN	I-NP	I-protein
50	50	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
DAILY	DAILY	NN	I-NP	I-protein
HOLD	HOLD	NN	I-NP	I-protein
IF	IF	NN	I-NP	I-protein
:	:	:	O	O
SBP	SBP	NN	B-NP	B-protein
<	<	SYM	O	O
90	90	CD	B-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Give	Give	NNP	I-NP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
3/9/06	3/9/06	CD	B-NP	O
by	by	IN	B-PP	O
VAZZANA	VAZZANA	NNP	B-NP	O
,	,	,	O	O
JAN	JAN	NNP	B-NP	O
M	M	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
M.P.H.	M.P.H.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
LISINOPRIL	LISINOPRIL	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
773304421	773304421	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
SPIRONOLACTONE	SPIRONOLACTONE	NNP	B-NP	O
&	&	CC	I-NP	O
LISINOPRIL	LISINOPRIL	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
monitor	monitor	VB	B-VP	O
Previous	Previous	JJ	B-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
3/9/06	3/9/06	CD	B-NP	O
by	by	IN	B-PP	O
SOLARSKI	SOLARSKI	NNP	B-NP	O
,	,	,	O	O
ERICH	ERICH	NNP	B-NP	O
S.	S.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
M.P.H.	M.P.H.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
KCL	KCL	NNP	B-NP	O
IMMEDIATE	IMMEDIATE	NNP	I-NP	O
RELEASE	RELEASE	NNP	I-NP	O
PO	PO	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
406317070	406317070	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
SPIRONOLACTONE	SPIRONOLACTONE	NNP	B-NP	O
&	&	CC	I-NP	O
POTASSIUM	POTASSIUM	NNP	I-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
monitored	monitor	VBN	B-NP	O
Previous	Previous	JJ	I-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
10/8/06	10/8/06	CD	B-NP	O
by	by	IN	B-PP	O
SCHWISOW	SCHWISOW	NNP	B-NP	O
,	,	,	O	O
CHUNG	CHUNG	NNP	B-NP	O
P	P	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
M.P.H.	M.P.H.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
POTASSIUM	POTASSIUM	NN	B-NP	O
CHLORIDE	CHLORIDE	NN	I-NP	O
IMMED	IMMED	NN	I-NP	O
.	.	.	O	O

REL	REL	NN	B-NP	B-protein
.	.	.	O	O

PO	PO	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
803441868	803441868	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
SPIRONOLACTONE	SPIRONOLACTONE	NNP	B-NP	O
&	&	CC	I-NP	O
POTASSIUM	POTASSIUM	NNP	I-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
monitor	monitor	VB	B-VP	O
Previous	Previous	JJ	B-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
10/8/06	10/8/06	CD	B-NP	O
by	by	IN	B-PP	O
TROTZ	TROTZ	NNP	B-NP	B-protein
,	,	,	O	O
HEATH	HEATH	NNP	B-NP	O
D.	D.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
PH.D.	PH.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
CAPTOPRIL	CAPTOPRIL	NN	B-NP	B-protein
PO	PO	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
ref	ref	NN	I-NP	I-protein
#	#	#	B-NP	I-protein
148635253	148635253	CD	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
SPIRONOLACTONE	SPIRONOLACTONE	NNP	B-NP	O
&	&	CC	I-NP	O
CAPTOPRIL	CAPTOPRIL	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
INSULIN	INSULIN	NNP	I-NP	O
ASPART	ASPART	NNP	I-NP	O
Sliding	Sliding	NNP	I-NP	O
Scale	Scale	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
subcutaneously	subcutaneously	RB	B-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
SC	SC	NN	I-NP	B-protein
AC	AC	NN	I-NP	I-protein
If	If	IN	B-SBAR	I-protein
BS	BS	NNP	B-NP	I-protein
is	be	VBZ	B-VP	O
less	less	JJR	B-NP	O
than	than	IN	I-NP	O
125	125	CD	I-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
0	0	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
125-150	125-150	CD	B-NP	O
,	,	,	O	O
then	then	RB	O	O
give	give	VB	B-VP	O
2	2	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
151-200	151-200	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
3	3	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
201-250	201-250	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
4	4	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
251-300	251-300	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
6	6	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
301-350	301-350	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
8	8	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
351-400	351-400	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
10	10	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
and	and	CC	O	O
call	call	VB	B-VP	O
HO	HO	NN	B-NP	B-protein
Call	Call	NN	I-NP	I-protein
HO	HO	NN	I-NP	I-protein
if	if	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
greater	great	JJR	B-ADJP	O
than	than	IN	B-PP	O
400	400	CD	B-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
Fluid	Fluid	NN	B-NP	O
restriction	restriction	NN	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
House	House	NNP	B-NP	O
/	/	SYM	B-NP	O
Low	Low	JJ	I-NP	O
chol/low	chol/low	NN	I-NP	O
sat	sat	NN	I-NP	O
.	.	.	O	O

fat	fat	JJ	B-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
2	2	CD	B-NP	O
gram	gram	NN	I-NP	O
Sodium	Sodium	NN	I-NP	O
ACTIVITY	ACTIVITY	NN	I-NP	O
:	:	:	O	O
Walking	Walk	VBG	B-VP	O
as	as	IN	B-SBAR	O
tolerated	tolerate	VBN	B-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
cardiology	cardiology	NN	B-NP	O
dr	dr	NN	I-NP	O
lelonek	lelonek	VBP	B-VP	O
445.966.7908	445.966.7908	CD	B-NP	O
1-4	1-4	CD	I-NP	O
weeks	week	NNS	I-NP	O
,	,	,	O	O
pcp	pcp	NN	B-NP	O
dr	dr	NN	I-NP	O
hoyt	hoyt	NN	I-NP	O
shimek	shimek	VBP	B-VP	O
161-943-8709	161-943-8709	CD	B-NP	O
2	2	CD	I-NP	O
weeks	week	NNS	I-NP	O
,	,	,	O	O
ALLERGY	ALLERGY	NN	B-NP	O
:	:	:	O	O
NKA	NKA	NN	B-NP	O
ADMIT	ADMIT	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
chf	chf	NN	B-NP	O
,	,	,	O	O
unstable	unstable	JJ	B-NP	O
angina	angina	NN	I-NP	O
PRINCIPAL	PRINCIPAL	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NNP	B-NP	O
for	for	IN	B-PP	O
Causing	Causing	NNP	B-NP	O
Admission	Admission	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
chf	chf	NN	I-NP	O
exacerbation	exacerbation	NN	I-NP	O
OTHER	OTHER	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
chf	chf	NN	I-NP	O
exacerbation	exacerbation	NN	I-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
none	none	NN	B-NP	O
OTHER	OTHER	NN	I-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
echo	echo	RB	B-NP	O
7/25	7/25	CD	I-NP	O
-	-	HYPH	B-ADJP	O
with	with	IN	B-PP	O
EF	EF	NN	B-NP	O
20-25	20-25	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
wall	wall	NN	B-NP	O
motion	motion	NN	I-NP	O
abnl	abnl	NN	I-NP	O
,	,	,	O	O
dil	dil	NN	B-NP	O
ivc	ivc	NN	I-NP	O
,	,	,	O	O
tr	tr	NN	B-NP	B-protein
,	,	,	O	O
mr.	mr.	NN	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
atrial	atrial	JJ	B-NP	O
septal	septal	JJ	I-NP	O
defect	defect	NN	I-NP	O
noted	note	VBD	B-VP	O
.	.	.	O	O

Mibi/PET-CT	Mibi/PET-CT	NN	B-NP	O
9/2	9/2	CD	I-NP	O
test	test	NN	I-NP	O
results	result	NNS	I-NP	O
are	be	VBP	B-VP	O
abnormal	abnormal	JJ	B-ADJP	O
and	and	CC	O	O
c/w	c/w	VB	B-VP	O
the	the	DT	B-NP	O
following	following	NN	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

A	A	DT	B-NP	O
medium	medium	JJ	I-NP	O
sized	sized	JJ	I-NP	O
region	region	NN	I-NP	O
of	of	IN	B-PP	O
myocardial	myocardial	JJ	B-NP	O
scar	scar	NN	I-NP	O
without	without	IN	B-PP	O
residual	residual	JJ	B-NP	O
ischemia	ischemia	NN	I-NP	O
or	or	CC	I-NP	O
viability	viability	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
distribution	distribution	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
mid-LAD	mid-LAD	NN	I-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

A	A	DT	B-NP	O
small	small	JJ	I-NP	O
region	region	NN	I-NP	O
of	of	IN	B-PP	O
myocardial	myocardial	JJ	B-NP	O
scar	scar	NN	I-NP	O
without	without	IN	B-PP	O
residual	residual	JJ	B-NP	O
ischemia	ischemia	NN	I-NP	O
or	or	CC	I-NP	O
viability	viability	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
distribution	distribution	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
PDA	PDA	NN	I-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Moderate	Moderate	JJ	B-NP	O
global	global	JJ	I-NP	O
LV	LV	NN	I-NP	O
systolic	systolic	JJ	I-NP	O
dysfunction	dysfunction	NN	I-NP	O
.	.	.	O	O

BRIEF	BRIEF	NN	B-NP	O
RESUME	RESUME	NN	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
CC	CC	NN	B-NP	O
-	-	HYPH	O	O
sent	send	VBN	B-VP	O
in	in	RP	B-PRT	O
by	by	IN	B-PP	O
pcp	pcp	NN	B-NP	O
for	for	IN	B-PP	O
chest	chest	NN	B-NP	O
pressure	pressure	NN	I-NP	O
HPI-66yo	HPI-66yo	NN	I-NP	O
M	M	NN	I-NP	O
spanish	spanish	NN	I-NP	O
speaking	speak	VBG	B-VP	O
from	from	IN	B-PP	O
O	O	NNP	B-NP	O
Ankament	Ankament	NNP	I-NP	O
Ta	Ta	NNP	I-NP	O
11/27	11/27	CD	I-NP	O
had	have	VBD	B-VP	O
labs	lab	NNS	B-NP	O
drawn	draw	VBN	B-VP	O
at	at	IN	B-PP	O
frelawn	frelawn	JJ	B-NP	O
dinghung	dinghung	NN	I-NP	O
ant	ant	JJ	I-NP	O
hospital	hospital	NN	I-NP	O
.	.	.	O	O

5/9	5/9	CD	B-NP	O
saw	see	VBD	B-VP	O
pcp	pcp	NN	B-NP	O
,	,	,	O	O
reported	report	VBD	B-VP	O
sig.cardiac	sig.cardiac	JJ	B-NP	O
hx	hx	NN	I-NP	O
.	.	.	O	O

and	and	CC	O	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
past	past	JJ	I-NP	O
few	few	JJ	I-NP	O
months	month	NNS	I-NP	O
has	have	VBZ	B-VP	O
had	have	VBN	I-VP	O
an	an	DT	B-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
chest	chest	NN	B-NP	O
pressure	pressure	NN	I-NP	O
,	,	,	O	O
nonradiating	nonradiating	JJ	B-NP	O
,	,	,	I-NP	O
initially	initially	RB	I-NP	O
sx	sx	NN	I-NP	O
on	on	IN	B-PP	O
exertion	exertion	NN	B-NP	O
,	,	,	O	O
most	most	RBS	B-ADVP	O
recently	recently	RB	I-ADVP	O
at	at	IN	B-PP	O
rest	rest	NN	B-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
sunday	sunday	NN	B-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
lying	lie	VBG	I-VP	O
on	on	IN	B-PP	O
couch	couch	NN	B-NP	O
when	when	WRB	B-ADVP	O
the	the	DT	B-NP	O
sx	sx	NN	I-NP	O
started	start	VBD	B-VP	O
,	,	,	O	O
took	take	VBD	B-VP	O
two	two	CD	B-NP	O
nitro	nitro	NN	I-NP	O
with	with	IN	B-PP	O
good	good	JJ	B-NP	O
resolution	resolution	NN	I-NP	O
.	.	.	O	O

no	no	DT	B-NP	O
sob	sob	NN	I-NP	B-protein
,	,	,	O	O
no	no	DT	B-NP	O
n/v/diaphoresis	n/v/diaphoresis	NN	I-NP	O
/	/	SYM	B-NP	O
fevers	fever	NNS	I-NP	O
.	.	.	O	O

he	he	PRP	B-NP	O
has	have	VBZ	B-VP	O
also	also	RB	I-VP	O
noted	note	VBN	I-VP	O
worsening	worsen	VBG	B-VP	O
LE	LE	NN	B-NP	O
edema	edema	NN	I-NP	O
and	and	CC	I-NP	O
weight	weight	NN	I-NP	O
gain	gain	NN	I-NP	O
of	of	IN	B-PP	O
30lbs	30lb	NNS	B-NP	O
over	over	IN	B-PP	O
this	this	DT	B-NP	O
time	time	NN	I-NP	O
period	period	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
admits	admit	VBZ	B-VP	O
to	to	TO	B-PP	O
missing	miss	VBG	B-VP	O
his	his	PRP$	B-NP	O
meds	med	NNS	I-NP	O
and	and	CC	B-PP	O
to	to	TO	B-PP	O
eating	eat	VBG	B-VP	O
a	a	DT	B-NP	O
lot	lot	NN	I-NP	O
of	of	IN	B-PP	O
salt	salt	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
worked	work	VBN	I-VP	O
up	up	RP	B-PRT	O
at	at	IN	B-PP	O
A	A	NNP	B-NP	O
in	in	IN	B-PP	O
Tonusni	Tonusni	NNP	B-NP	O
for	for	IN	B-PP	O
several	several	JJ	B-NP	O
months	month	NNS	I-NP	O
to	to	TO	B-VP	O
try	try	VB	I-VP	O
and	and	CC	I-VP	O
determine	determine	VB	I-VP	O
how	how	WRB	B-ADVP	O
to	to	TO	B-VP	O
best	good	JJS	I-VP	O
treat	treat	VB	I-VP	O
his	his	PRP$	B-NP	O
cardiac	cardiac	JJ	I-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

Per	Per	IN	B-PP	O
the	the	DT	B-NP	O
pt	pt	NN	I-NP	O
,	,	,	O	O
they	they	PRP	B-NP	O
said	say	VBD	B-VP	O
they	they	PRP	B-NP	O
could	could	MD	B-VP	O
n't	n't	RB	I-VP	O
do	do	VB	I-VP	O
anything	anything	NN	B-NP	O
for	for	IN	B-PP	O
him	him	PRP	B-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
ED	ED	NN	B-NP	O
,	,	,	O	O
afebrile	afebrile	JJ	B-NP	O
hr	hr	NN	I-NP	O
60s	60	NNS	I-NP	O
,	,	,	O	O
BP	BP	NN	B-NP	O
110s	110	NNS	I-NP	O
sat	sit	VBD	B-VP	O
100	100	CD	B-NP	O
%	%	NN	I-NP	O
RA	RA	NN	I-NP	O
.	.	.	O	O
.	.	.	O	O

Tx	Tx	NN	B-NP	O
with	with	IN	B-PP	O
lasix	lasix	NN	B-NP	O
80iiv	80iiv	NN	I-NP	O
,	,	,	O	O
asa	asa	NN	B-NP	O
325	325	CD	I-NP	O
,	,	,	O	O
coreg	coreg	NN	B-NP	O
6.25	6.25	CD	I-NP	O
,	,	,	O	O
inuslin	inuslin	NN	B-NP	O
8u	8u	NN	I-NP	O
.	.	.	O	O

OU	OU	NN	B-NP	O
1500	1500	CD	I-NP	O
.	.	.	O	O

CXR	CXR	NN	B-NP	O
c/w	c/w	NN	I-NP	O
pulm	pulm	NN	I-NP	O
edema	edema	NN	I-NP	O
Exam	Exam	NN	I-NP	O
Gen	Gen	NN	I-NP	O
-	-	HYPH	O	O
resting	rest	VBG	B-VP	O
comfortably	comfortably	RB	B-ADVP	O
in	in	IN	B-PP	O
bed	bed	NN	B-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
c/o	c/o	NN	I-NP	O
HEENT	HEENT	NN	I-NP	O
-	-	HYPH	O	O
jvp	jvp	NN	B-NP	O
to	to	TO	B-VP	O
jaw	jaw	VB	I-VP	O
Pulm	Pulm	NN	B-NP	B-protein
-	-	HYPH	B-NP	O
b/l	b/l	NN	I-NP	O
crackles	crackle	NNS	I-NP	O
at	at	IN	B-PP	O
bases	base	NNS	B-NP	O
Abd	Abd	NN	I-NP	B-protein
-	-	HYPH	B-VP	O
soft	soft	JJ	B-ADJP	O
,	,	,	O	O
NT	NT	NNP	B-NP	O
,	,	,	O	O
ND	ND	NNP	B-NP	O
Ext	Ext	NNP	I-NP	O
-	-	HYPH	B-NP	O
c/o	c/o	NN	I-NP	O
rt	rt	NN	I-NP	O
foot	foot	NN	I-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
signs	sign	NNS	I-NP	O
of	of	IN	B-PP	O
trauma	trauma	NN	B-NP	O
.	.	.	O	O

slight	slight	JJ	B-NP	O
edema	edema	NN	I-NP	O
,	,	,	O	O
b/l	b/l	NN	B-NP	O
,	,	,	O	O
c/o	c/o	NN	B-NP	O
ttp	ttp	NN	I-NP	O
along	along	IN	B-PP	O
top	top	NN	B-NP	O
of	of	IN	B-PP	O
left	left	NN	B-NP	O
.	.	.	O	O

DPs	DP	NNS	B-NP	O
not	not	RB	O	O
palpable	palpable	JJ	B-NP	O
Home	Home	NN	I-NP	O
meds	med	VBZ	B-VP	O
plavix75	plavix75	NN	B-NP	B-protein
asa81	asa81	NN	I-NP	I-protein
carnitidine	carnitidine	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
?	?	.	O	O
-RRB-	-RRB-	NNP	B-NP	O

150	150	CD	B-NP	O
bid	bid	NN	I-NP	O
imdur	imdur	IN	B-PP	O
30	30	CD	B-NP	O
digitek	digitek	NN	I-NP	O
0.125	0.125	CD	B-NP	O
lasix	lasix	CD	I-NP	O
80	80	CD	I-NP	O
coreg	coreg	NN	I-NP	O
6.25	6.25	CD	B-NP	O
spironolactone	spironolactone	NN	I-NP	O
50	50	CD	B-NP	O
insulin	insulin	NN	I-NP	O
70/30	70/30	CD	B-NP	O
50qam	50qam	CD	I-NP	O
,	,	,	O	O
35	35	CD	B-NP	O
qpm	qpm	NN	I-NP	O
NKDA	NKDA	NN	I-NP	O
PMH	PMH	NN	I-NP	O
mi	mi	NNS	I-NP	O
x3	x3	CD	B-NP	O
-LRB-	-LRB-	HYPH	I-NP	O
1993	1993	CD	I-NP	O
-RRB-	-RRB-	SYM	O	O
-	-	HYPH	O	O
?	?	.	O	O

cath	cath	NN	B-NP	O
,	,	,	O	O
?	?	.	O	O

inoperable	inoperable	JJ	B-ADJP	O
,	,	,	O	O
knows	know	VBZ	B-VP	O
he	he	PRP	B-NP	O
has	have	VBZ	B-VP	O
3v	3v	CD	B-NP	O
dz	dz	NN	I-NP	O
htn	htn	NN	I-NP	O
chf	chf	NN	I-NP	O
gerd	gerd	NN	I-NP	O
dm	dm	NN	I-NP	O
Shx	Shx	NNP	I-NP	O
from	from	IN	B-PP	O
U	U	NNP	B-NP	O
Salosra	Salosra	NNP	I-NP	O
Scot	Scot	NNP	I-NP	O
exsmoker	exsmoker	NN	I-NP	O
quit	quit	VBD	B-VP	O
5y	5y	JJ	B-NP	O
pta	pta	NN	I-NP	O
no	no	DT	B-NP	O
etoh	etoh	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
ivdu	ivdu	NN	I-NP	O
FHx	FHx	NN	I-NP	O
brother	brother	NN	I-NP	O
died	die	VBD	B-VP	O
of	of	IN	B-PP	O
MI	MI	NN	B-NP	B-protein
5/15	5/15	CD	I-NP	I-protein
in	in	IN	B-PP	O
50s	50s	CD	B-NP	O
parents	parent	NNS	I-NP	O
died	die	VBD	B-VP	O
of	of	IN	B-PP	O
CAD	CAD	NN	B-NP	B-protein
in	in	IN	B-PP	O
70s/80s	70s/80s	CD	B-NP	O
htn	htn	NN	I-NP	O
,	,	,	O	O
dm	dm	NN	B-NP	O
studies	study	NNS	I-NP	O
cxr	cxr	VBP	B-VP	O
10/2	10/2	CD	B-NP	O
cardiomegaly	cardiomegaly	NN	I-NP	O
,	,	,	O	O
increased	increase	VBN	B-NP	O
interstitial	interstitial	JJ	I-NP	O
marking	marking	NN	I-NP	O
c/w	c/w	NN	I-NP	O
pulm	pulm	NN	I-NP	O
edema	edema	NN	I-NP	O
ekg	ekg	NN	I-NP	O
-	-	HYPH	O	O
nsr	nsr	NN	B-NP	O
1	1	CD	I-NP	O
degree	degree	NN	I-NP	O
avblock	avblock	NN	I-NP	O
,	,	,	O	O
nl	nl	NN	B-NP	O
axis	axis	NN	I-NP	O
,	,	,	O	O
q	q	NN	B-NP	O
in	in	IN	B-PP	O
v1-v3	v1-v3	NN	B-NP	O
,	,	,	O	O
poor	poor	JJ	B-NP	O
r	r	NN	I-NP	O
waves	wave	NNS	I-NP	O
in	in	IN	B-PP	O
v4-v5	v4-v5	NN	B-NP	O
,	,	,	O	O
T	T	NN	B-NP	B-protein
inversion	inversion	NN	I-NP	I-protein
3	3	CD	I-NP	I-protein
,	,	,	O	O
avf	avf	NN	B-NP	O
,	,	,	O	O
biphasic	biphasic	JJ	B-NP	O
Ts	T	NNS	I-NP	O
and	and	CC	O	O
mild	mild	JJ	B-NP	O
depression	depression	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
<	<	SYM	O	O
0.5	0.5	CD	B-NP	O
mm	mm	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
in	in	IN	B-PP	O
v5	v5	NN	B-NP	B-protein
echo	echo	HYPH	B-NP	I-protein
7/25	7/25	CD	I-NP	I-protein
-	-	HYPH	B-ADJP	O
with	with	IN	B-PP	O
EF	EF	NN	B-NP	O
20-25	20-25	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
wall	wall	NN	B-NP	O
motion	motion	NN	I-NP	O
abnl	abnl	NN	I-NP	O
,	,	,	O	O
dil	dil	NN	B-NP	O
ivc	ivc	NN	I-NP	O
,	,	,	O	O
tr	tr	NN	B-NP	B-protein
,	,	,	O	O
mr.	mr.	NN	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
ASD	ASD	NN	B-NP	O
seen	see	VBN	B-VP	O
.	.	.	O	O

Mibi	Mibi	NNP	B-NP	O
9/2	9/2	CD	I-NP	O
no	no	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
reversible	reversible	JJ	B-NP	O
ischemia	ischemia	NN	I-NP	O
assessment	assessment	NN	I-NP	O
and	and	CC	O	O
plan	plan	NN	B-NP	O
66yo	66yo	CD	I-NP	O
with	with	IN	B-PP	O
cad/mi	cad/mi	NN	B-NP	O
,	,	,	O	O
dm	dm	NN	B-NP	O
,	,	,	O	O
chf	chf	NN	B-NP	O
,	,	,	O	O
admitted	admit	VBN	B-VP	O
for	for	IN	B-PP	O
chf	chf	NN	B-NP	O
exacerbation	exacerbation	NN	I-NP	O
and	and	CC	I-NP	O
r/o	r/o	NN	I-NP	B-protein
MI	MI	NN	I-NP	I-protein
1	1	CD	I-NP	I-protein
.	.	.	O	O

CV	CV	NN	B-NP	O
-	-	HYPH	I-NP	O
a.	a.	NN	I-NP	O
ischemia	ischemia	NN	I-NP	O
-	-	HYPH	B-NP	O
sig	sig	NN	I-NP	O
cad	cad	NN	I-NP	O
with	with	IN	B-PP	O
hx	hx	NN	B-NP	O
of	of	IN	B-PP	O
chest	chest	NN	B-NP	O
presure	presure	NN	I-NP	O
at	at	IN	B-PP	O
rest	rest	NN	B-NP	O
,	,	,	O	O
ce	ce	NN	B-NP	O
-	-	HYPH	B-NP	O
x2	x2	NN	I-NP	O
.	.	.	O	O

ekg	ekg	NN	B-NP	O
abnl	abnl	NN	I-NP	O
w/o	w/o	NN	I-NP	O
priors	prior	NNS	I-NP	O
,	,	,	O	O
concerning	concern	VBG	B-VP	O
for	for	IN	B-PP	O
unstable	unstable	JJ	B-NP	O
angina	angina	NN	I-NP	O
.	.	.	O	O

given	give	VBN	B-PP	O
asa	asa	NN	B-NP	O
,	,	,	O	O
carvedilol	carvedilol	NN	B-NP	B-protein
-LRB-	-LRB-	NN	I-NP	I-protein
changed	change	VBD	B-VP	O
to	to	TO	I-VP	O
lisinopril	lisinopril	VB	I-VP	O
7/26	7/26	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
lipitor	lipitor	NN	B-NP	O
,	,	,	O	O
plavix	plavix	NN	B-NP	O
and	and	CC	O	O
started	start	VBN	B-VP	O
on	on	IN	B-PP	O
lovenox	lovenox	NN	B-NP	O
100	100	CD	I-NP	O
sq.	sq.	NN	I-NP	O
.	.	.	O	O

Lovenox	Lovenox	NN	B-NP	O
was	be	VBD	B-VP	O
stopped	stop	VBN	I-VP	O
when	when	WRB	B-ADVP	O
ce	ce	NN	B-NP	B-protein
neg	neg	NN	I-NP	I-protein
x3	x3	NN	I-NP	I-protein
on	on	IN	B-PP	O
7/25	7/25	CD	B-NP	O
.	.	.	O	O

Lipid	Lipid	NN	B-NP	O
panel	panel	NN	I-NP	O
ok	ok	NN	I-NP	O
,	,	,	O	O
continue	continue	VBP	B-VP	O
on	on	IN	B-PP	O
lipitor	lipitor	NN	B-NP	O
80	80	CD	I-NP	O
.	.	.	O	O

Has	Ha	NNS	B-NP	B-protein
been	be	VBN	B-VP	O
CP	CP	NN	B-ADJP	B-DNA
free	free	JJ	I-ADJP	O
since	since	IN	B-PP	O
Sunday	Sunday	NNP	B-NP	O
.	.	.	O	O

Stressed	Stress	VBN	B-VP	O
on	on	IN	B-PP	O
7/26	7/26	CD	B-NP	O
,	,	,	O	O
results	result	NNS	B-NP	O
show	show	VBP	B-VP	O
no	no	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
reversible	reversible	JJ	B-NP	O
ischemia	ischemia	NN	I-NP	O
and	and	CC	I-NP	O
pt	pt	NN	I-NP	O
has	have	VBZ	B-VP	O
had	have	VBN	I-VP	O
no	no	DT	B-NP	O
CP	CP	NN	I-NP	B-DNA
while	while	IN	B-SBAR	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
hospital	hospital	NN	I-NP	O
.	.	.	O	O

b.	b.	LS	B-NP	O
pump	pump	NN	I-NP	O
-	-	HYPH	B-NP	O
chf	chf	NN	I-NP	O
exacerbation	exacerbation	NN	I-NP	O
,	,	,	O	O
likely	likely	RB	B-NP	O
2/2	2/2	CD	I-NP	O
not	not	RB	O	O
taking	take	VBG	B-VP	O
meds	med	NNS	B-NP	O
and	and	CC	O	O
poor	poor	JJ	B-NP	O
diet	diet	NN	I-NP	O
control	control	NN	I-NP	O
.	.	.	O	O

will	will	MD	B-VP	O
txc	txc	VB	I-VP	O
with	with	IN	B-PP	O
lasix	lasix	NN	B-NP	O
40iv	40iv	CD	I-NP	O
bid	bid	NN	I-NP	O
,	,	,	O	O
goals	goal	NNS	B-NP	O
-1	-1	CD	B-NP	O
liter/day	liter/day	NN	I-NP	O
.	.	.	O	O

pt	pt	NN	B-NP	O
already	already	RB	B-ADVP	O
improving	improve	VBG	B-VP	O
-	-	HYPH	B-NP	O
good	good	JJ	I-NP	O
diuresis	diuresis	NN	I-NP	O
with	with	IN	B-PP	O
lasix	lasix	NN	B-NP	O
40iv	40iv	CD	I-NP	O
.	.	.	O	O

continue	continue	JJ	B-NP	O
home	home	NN	I-NP	O
spironolactone	spironolactone	NN	I-NP	O
,	,	,	O	O
restarted	restart	VBD	B-VP	O
on	on	IN	B-PP	O
home	home	NN	B-NP	O
imdur	imdur	NN	I-NP	O
.	.	.	O	O

ACEi	ACEi	NNP	B-NP	O
started	start	VBD	B-VP	O
and	and	CC	I-VP	O
increased	increase	VBD	I-VP	O
to	to	TO	B-PP	O
10mg	10mg	CD	B-NP	O
qd	qd	NN	I-NP	O
.	.	.	O	O

fluid	fluid	NN	B-NP	O
restricted	restricted	JJ	B-ADJP	O
to	to	TO	B-PP	O
2L	2L	NN	B-NP	B-protein
.	.	.	O	O

echo	echo	RB	B-NP	O
7/25	7/25	CD	I-NP	O
with	with	IN	B-PP	O
EF	EF	NN	B-NP	O
20-25	20-25	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
wall	wall	NN	B-NP	O
motion	motion	NN	I-NP	O
abnl	abnl	NN	I-NP	O
,	,	,	O	O
dil	dil	NN	B-NP	O
ivc	ivc	NN	I-NP	O
,	,	,	O	O
tr	tr	NN	B-NP	B-protein
,	,	,	O	O
mr.	mr.	NNP	B-NP	O
Patient	Patient	NNP	I-NP	O
has	have	VBZ	B-VP	O
diuresed	diurese	VBN	I-VP	O
well	well	RB	B-ADVP	O
during	during	IN	B-PP	O
his	his	PRP$	B-NP	O
time	time	NN	I-NP	O
in	in	IN	B-PP	O
house	house	NN	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
weight	weight	NN	I-NP	O
on	on	IN	B-PP	O
dc	dc	NN	B-NP	B-cell_type
of	of	IN	B-PP	O
82	82	CD	B-NP	O
kg.Continue	kg.Continue	NN	I-NP	O
on	on	IN	B-PP	O
lasix	lasix	NN	B-NP	B-protein
80po	80po	CD	I-NP	I-protein
daily	daily	RB	B-ADVP	O
.	.	.	O	O

c.	c.	LS	B-NP	O
rhythm	rhythm	NN	I-NP	O
-	-	HYPH	O	O
sinus	sinus	NN	B-NP	O
,	,	,	O	O
on	on	IN	B-PP	O
tele	tele	NN	B-NP	O
.	.	.	O	O

long	long	RB	B-ADVP	O
Pr	Pr	NNP	B-NP	O
interval	interval	NN	I-NP	O
noted	note	VBD	B-VP	O
,	,	,	O	O
dig	dig	NN	B-NP	O
stopped	stop	VBD	B-VP	O
to	to	TO	I-VP	O
avoid	avoid	VB	I-VP	O
any	any	DT	B-NP	O
additional	additional	JJ	I-NP	O
PR	PR	NN	I-NP	B-protein
prolongation	prolongation	NN	I-NP	O
.	.	.	O	O

may	may	MD	B-VP	O
need	need	VB	I-VP	O
EP	EP	NN	B-NP	B-protein
workup	workup	NN	I-NP	I-protein
in	in	IN	B-PP	O
the	the	DT	B-NP	O
future	future	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

pulm	pulm	NN	B-NP	O
-	-	HYPH	I-NP	O
cardiogenic	cardiogenic	JJ	I-NP	O
pulm	pulm	NN	I-NP	O
edema	edema	NN	I-NP	O
,	,	,	O	O
imprving	imprve	VBG	B-VP	O
.	.	.	O	O

sat	sit	VBD	B-VP	O
stable	stable	JJ	B-ADJP	O
on	on	IN	B-PP	O
RA	RA	NN	B-NP	B-protein
.	.	.	O	O

continue	continue	JJ	B-NP	O
diuresis	diuresis	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
room	room	NN	B-NP	O
air	air	NN	I-NP	O
throughout	throughout	IN	B-PP	O
his	his	PRP$	B-NP	O
time	time	NN	I-NP	O
in	in	IN	B-PP	O
house	house	NN	B-NP	O
,	,	,	O	O
appears	appear	VBZ	B-VP	O
very	very	RB	B-ADJP	O
comfortable	comfortable	JJ	I-ADJP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

GI	GI	NN	B-NP	O
-	-	HYPH	O	O
mild	mild	JJ	B-NP	O
transaminitis	transaminitis	NN	I-NP	O
-	-	HYPH	O	O
decreased	decrease	VBN	B-VP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
time	time	NN	I-NP	O
here	here	RB	B-ADVP	O
and	and	CC	O	O
normal	normal	JJ	B-NP	O
AST/ALT/Tbili	AST/ALT/Tbili	NN	I-NP	O
on	on	IN	B-PP	O
day	day	NN	B-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

Alk	Alk	NN	B-NP	O
phos	pho	NNS	I-NP	O
contiues	contiue	VBZ	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
elevated	elevate	VBN	I-VP	O
at	at	IN	B-PP	O
175	175	CD	B-NP	O
.	.	.	O	O

Will	Will	MD	B-VP	O
need	need	VB	I-VP	O
pcp	pcp	NN	B-NP	O
follow	follow	VB	B-VP	O
up	up	RP	B-PRT	O
evaluation	evaluation	NN	B-NP	O
,	,	,	O	O
but	but	CC	O	O
no	no	DT	B-NP	O
abdominal	abdominal	JJ	I-NP	O
complaints	complaint	NNS	I-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Heme	Heme	NN	B-NP	B-protein
-	-	:	O	O
on	on	IN	B-PP	O
lovenox	lovenox	NN	B-NP	O
for	for	IN	B-PP	O
UA	UA	NNP	B-NP	O
,	,	,	O	O
transitioned	transitione	VBN	B-VP	O
to	to	TO	B-PP	O
SC	SC	NN	B-NP	O
DVT	DVT	NN	I-NP	O
ppx	ppx	NN	I-NP	O
dosing	dosing	NN	I-NP	O
on	on	IN	B-PP	O
7/25	7/25	CD	B-NP	O
,	,	,	O	O
on	on	IN	B-PP	O
plavix	plavix	NN	B-NP	O
for	for	IN	B-PP	O
?	?	.	O	O

stent	stent	JJ	B-ADJP	O
.	.	.	O	O

Will	Will	MD	B-VP	O
continue	continue	VB	I-VP	O
on	on	IN	B-PP	O
plavix	plavix	NN	B-NP	O
and	and	CC	I-NP	O
asa	asa	NN	I-NP	O
as	as	IN	B-PP	O
outpt	outpt	NN	B-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

endo	endo	AFX	B-NP	O
-	-	HYPH	I-NP	O
nph	nph	NN	B-NP	O
18	18	CD	I-NP	O
bid	bid	NN	I-NP	O
for	for	IN	B-PP	O
now	now	RB	B-NP	O
-LRB-	-LRB-	HYPH	I-NP	O
inc	inc	NN	I-NP	O
from	from	IN	B-PP	O
home	home	NN	B-NP	B-protein
10	10	CD	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
,	,	,	O	O
6u	6u	NN	B-NP	O
ac	ac	NN	I-NP	O
and	and	CC	I-NP	O
ss	ss	NN	I-NP	O
.	.	.	O	O

hgb	hgb	NN	B-NP	B-protein
a1c	a1c	NN	I-NP	I-protein
10.4	10.4	CD	I-NP	I-protein
-	-	HYPH	O	O
indicating	indicate	VBG	B-VP	O
need	need	NN	B-NP	O
for	for	IN	B-PP	O
tighter	tight	JJR	B-NP	O
glucose	glucose	NN	I-NP	O
control	control	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
will	will	MD	B-VP	O
go	go	VB	I-VP	O
home	home	NN	B-ADVP	O
on	on	IN	B-PP	O
an	an	DT	B-NP	O
increased	increase	VBN	I-NP	O
dose	dose	NN	I-NP	O
on	on	IN	B-PP	O
NPH	NPH	NN	B-NP	O
and	and	CC	O	O
advised	advise	VBN	B-VP	O
to	to	TO	B-VP	O
keep	keep	VB	I-VP	O
tight	tight	JJ	B-NP	O
control	control	NN	I-NP	O
over	over	IN	B-PP	O
his	his	PRP$	B-NP	O
blood	blood	NN	I-NP	O
sugar	sugar	NN	I-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

msk	msk	NN	B-NP	B-protein
-	-	HYPH	I-NP	O
c/o	c/o	NN	I-NP	B-protein
left	leave	VBD	B-VP	I-protein
foot	foot	NN	B-NP	I-protein
pain	pain	NN	I-NP	I-protein
,	,	,	O	O
unclear	unclear	JJ	B-NP	O
source	source	NN	I-NP	O
.	.	.	O	O

xray	xray	VB	B-VP	O
final	final	JJ	B-NP	O
read	read	NN	I-NP	O
shows	show	VBZ	B-VP	O
degenerative	degenerative	JJ	B-NP	O
changes	change	NNS	I-NP	O
.	.	.	O	O

able	able	JJ	B-ADJP	O
to	to	TO	B-VP	O
doppler	doppler	VB	I-VP	O
DPs	DP	NNS	B-NP	B-protein
.	.	.	O	O
?	?	.	O	O

claudication	claudication	NN	B-NP	O
?	?	.	O	O

Patient	Patient	NN	B-NP	O
is	be	VBZ	B-VP	O
pain	pain	RB	B-ADJP	O
free	free	JJ	I-ADJP	O
now	now	RB	B-ADVP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

fen	fen	NN	B-NP	O
-	-	HYPH	O	O
ada	ada	SYM	B-NP	O
,	,	,	O	O
cardiac	cardiac	JJ	B-NP	O
diet	diet	NN	I-NP	O
.	.	.	O	O

Lytes	Lyte	NNS	B-NP	O
repleted	replete	VBD	B-VP	O
while	while	IN	B-SBAR	O
in	in	IN	B-PP	O
house	house	NN	B-NP	O
,	,	,	O	O
all	all	DT	B-NP	O
normal	normal	JJ	B-ADJP	O
on	on	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
is	be	VBZ	B-VP	O
staible	staible	JJ	B-ADJP	O
for	for	IN	B-PP	O
discharge	discharge	NN	B-NP	O
home	home	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
will	will	MD	B-VP	O
need	need	VB	I-VP	O
to	to	TO	I-VP	O
followup	followup	VB	I-VP	O
with	with	IN	B-PP	O
cardiology	cardiology	NN	B-NP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpt	outpt	NN	I-NP	O
.	.	.	O	O

ADDITIONAL	ADDITIONAL	JJ	B-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

take	take	VB	B-VP	O
all	all	DT	B-NP	O
your	your	PRP$	I-NP	O
medications	medication	NNS	I-NP	O
as	as	IN	B-SBAR	O
directed	direct	VBN	B-VP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Weigh	Weigh	VB	B-VP	O
yourself	yourself	PRP	B-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
if	if	IN	B-SBAR	O
you	you	PRP	B-NP	O
start	start	VBP	B-VP	O
to	to	TO	I-VP	O
gain	gain	VB	I-VP	O
weight	weight	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
even	even	RB	B-NP	O
5	5	CD	I-NP	O
pounds	pound	NNS	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
you	you	PRP	B-NP	O
need	need	VBP	B-VP	O
to	to	TO	I-VP	O
contact	contact	VB	I-VP	O
your	your	PRP$	B-NP	O
doctor	doctor	NN	I-NP	O
about	about	IN	B-PP	O
increasing	increase	VBG	B-VP	O
your	your	PRP$	B-NP	O
lasix	lasix	NN	I-NP	O
dose	dose	NN	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Follow	Follow	VB	B-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
cardiology	cardiology	NN	B-NP	O
as	as	IN	B-SBAR	O
directed	direct	VBN	B-VP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

check	check	VB	B-VP	O
you	you	PRP	B-NP	O
blood	blood	NN	B-NP	O
sugars	sugar	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
morning	morning	NN	I-NP	O
and	and	CC	B-PP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
.	.	.	O	O

adjust	adjust	VB	B-VP	O
your	your	PRP$	B-NP	O
insulin	insulin	NN	I-NP	B-protein
as	as	IN	B-SBAR	O
needed	need	VBN	B-VP	O
.	.	.	O	O

dr	dr	NN	B-NP	O
erick	erick	NN	I-NP	O
bedaw	bedaw	NN	I-NP	O
at	at	IN	B-PP	O
carlekadl	carlekadl	NN	B-NP	O
rine	rine	NN	I-NP	O
calccal	calccal	JJ	I-NP	O
memorial	memorial	JJ	I-NP	O
hospital	hospital	NN	I-NP	O
of	of	IN	B-PP	O
county	county	NN	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
following	follow	VBG	I-VP	O
his	his	PRP$	B-NP	O
blood	blood	NN	I-NP	O
sugars	sugar	NNS	I-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

get	get	VB	B-VP	O
a	a	DT	B-NP	O
recheck	recheck	NN	I-NP	O
of	of	IN	B-PP	O
your	your	PRP$	B-NP	O
lfts	lft	NNS	I-NP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpt	outpt	NN	I-NP	O
,	,	,	O	O
your	your	PRP$	B-NP	O
Alk	Alk	NNP	I-NP	B-protein
Phos	Phos	NNP	I-NP	O
and	and	CC	O	O
GGT	GGT	NN	B-NP	B-protein
were	be	VBD	B-VP	O
elevated	elevate	VBN	I-VP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

take	take	VB	B-VP	O
all	all	DT	B-NP	O
your	your	PRP$	I-NP	O
medications	medication	NNS	I-NP	O
as	as	IN	B-SBAR	O
directed	direct	VBN	B-VP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Weigh	Weigh	VB	B-VP	O
yourself	yourself	PRP	B-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
if	if	IN	B-SBAR	O
you	you	PRP	B-NP	O
start	start	VBP	B-VP	O
to	to	TO	I-VP	O
gain	gain	VB	I-VP	O
weight	weight	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
even	even	RB	B-NP	O
5	5	CD	I-NP	O
pounds	pound	NNS	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
you	you	PRP	B-NP	O
need	need	VBP	B-VP	O
to	to	TO	I-VP	O
contact	contact	VB	I-VP	O
your	your	PRP$	B-NP	O
doctor	doctor	NN	I-NP	O
about	about	IN	B-PP	O
increasing	increase	VBG	B-VP	O
your	your	PRP$	B-NP	O
lasix	lasix	NN	I-NP	O
dose	dose	NN	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Follow	Follow	VB	B-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
cardiology	cardiology	NN	B-NP	O
as	as	IN	B-SBAR	O
directed	direct	VBN	B-VP	O
.	.	.	O	O

No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
DONNA	DONNA	NNP	B-NP	O
,	,	,	O	O
EMMANUEL	EMMANUEL	NNP	B-NP	O
E	E	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
M.P.H.	M.P.H.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
OP416	OP416	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
1/29/06	1/29/06	CD	I-NP	O
@	@	NN	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
54	54	CD	B-NP	O
PM	PM	NN	I-NP	O
******	******	SYM	B-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

